{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:22:16Z","timestamp":1790266936461,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001465","name":"American Thoracic Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.chest.2020.01.026","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T17:34:37Z","timestamp":1580837677000},"page":"226-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Association of Medication Adherence and Clinical Outcomes in Sarcoidosis"],"prefix":"10.1016","volume":"158","author":[{"given":"Michelle","family":"Sharp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S.","family":"Rand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Moller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle N.","family":"Eakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.chest.2020.01.026_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrrheum.2011.93","article-title":"Sarcoidosis--scientific progress and clinical challenges","volume":"7","author":"Chen","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.chest.2020.01.026_bib2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1164\/ajrccm.150.4.7921471","article-title":"The epidemiology of interstitial lung diseases","volume":"150","author":"Coultas","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 6","key":"10.1016\/j.chest.2020.01.026_bib3","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1513\/AnnalsATS.201707-564OT","article-title":"Disease burden and variability in sarcoidosis","volume":"14","author":"Gerke","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"suppl 5","key":"10.1016\/j.chest.2020.01.026_bib4","first-page":"v1","article-title":"Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society","volume":"63","author":"Bradley","year":"2008","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.chest.2020.01.026_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/thx.51.3.238","article-title":"British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment","volume":"51","author":"Gibson","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.chest.2020.01.026_bib6","series-title":"Adherence to Long-Term Therapies: Evidence for Action","author":"Sabate","year":"2003"},{"issue":"5","key":"10.1016\/j.chest.2020.01.026_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM200008033430504","article-title":"Low-dose inhaled corticosteroids and the prevention of death from asthma","volume":"343","author":"Suissa","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.chest.2020.01.026_bib8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thx.2009.113662","article-title":"Adherence to inhaled therapy, mortality and hospital admission in COPD","volume":"64","author":"Vestbo","year":"2009","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.chest.2020.01.026_bib9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2011.03.005","article-title":"Longitudinal association between medication adherence and lung health in people with cystic fibrosis","volume":"10","author":"Eakin","year":"2011","journal-title":"J\u00a0Cyst Fibros"},{"issue":"91","key":"10.1016\/j.chest.2020.01.026_bib10","article-title":"Determinants of patient adherence: a review of systematic reviews","volume":"4","author":"Kardas","year":"2013","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.chest.2020.01.026_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjopharm.2010.03.002","article-title":"Racial differences in medication adherence: a cross-sectional study of Medicare enrollees","volume":"8","author":"Gerber","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"issue":"4","key":"10.1016\/j.chest.2020.01.026_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1081-1206(10)60532-7","article-title":"Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the Medication Adherence Report Scale for Asthma","volume":"103","author":"Cohen","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10","key":"10.1016\/j.chest.2020.01.026_bib13","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00228-012-1279-5","article-title":"Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD)","volume":"68","author":"Khdour","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.chest.2020.01.026_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/15412555.2014.922067","article-title":"Chronic obstructive pulmonary disease illness and medication beliefs are associated with medication adherence","volume":"12","author":"Krauskopf","year":"2015","journal-title":"Copd"},{"issue":"7","key":"10.1016\/j.chest.2020.01.026_bib15","first-page":"691","article-title":"Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data","volume":"20","author":"McAdam-Marx","year":"2014","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"9","key":"10.1016\/j.chest.2020.01.026_bib16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0149-2918(00)80089-2","article-title":"American translation, modification, and validation of the St. George's Respiratory Questionnaire","volume":"22","author":"Barr","year":"2000","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.chest.2020.01.026_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0954-6111(89)80199-4","article-title":"Measuring functional status in chronic lung disease: conclusions from a randomized control trial","volume":"83","author":"Guyatt","year":"1989","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.chest.2020.01.026_bib18","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A\u00a0self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"7","key":"10.1016\/j.chest.2020.01.026_bib19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2020.01.026_bib20","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","article-title":"Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis","volume":"44","author":"Judson","year":"2014","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2020.01.026_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/thoraxjnl-2012-201962","article-title":"The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status","volume":"68","author":"Patel","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.chest.2020.01.026_bib22","first-page":"75","article-title":"Validation of the King's Sarcoidosis Questionnaire (KSQ) in a Dutch sarcoidosis population","volume":"33","author":"Van Manen","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"3","key":"10.1016\/j.chest.2020.01.026_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00408-017-9994-4","article-title":"Repository corticotropin for chronic pulmonary sarcoidosis","volume":"195","author":"Baughman","year":"2017","journal-title":"Lung"},{"issue":"11","key":"10.1016\/j.chest.2020.01.026_bib24","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/MLR.0b013e3180616c1b","article-title":"Development and validation of a short-form, rapid estimate of adult literacy in medicine","volume":"45","author":"Arozullah","year":"2007","journal-title":"Med Care"},{"issue":"10","key":"10.1016\/j.chest.2020.01.026_bib25","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1513\/AnnalsATS.201503-172OT","article-title":"Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) study. Sarcoidosis protocol","volume":"12","author":"Moller","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.chest.2020.01.026_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"issue":"6","key":"10.1016\/j.chest.2020.01.026_bib27","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.22898","article-title":"Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting","volume":"57","author":"Koneru","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.chest.2020.01.026_bib28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.chest.2020.01.026_bib29","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/archinte.1995.00430080088011","article-title":"Prolonged use of methotrexate for sarcoidosis","volume":"155","author":"Lower","year":"1994","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.chest.2020.01.026_bib30","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.12-1728","article-title":"Methotrexate vs\u00a0azathioprine in second-line therapy of sarcoidosis","volume":"144","author":"Vorselaars","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2020.01.026_bib31","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/dc07-1924","article-title":"Medication adherence and racial differences in A1C control","volume":"31","author":"Adams","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.chest.2020.01.026_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/02770900701815552","article-title":"Do asthma medication beliefs mediate the relationship between minority status and adherence to therapy?","volume":"45","author":"Le","year":"2008","journal-title":"J\u00a0Asthma"},{"issue":"4","key":"10.1016\/j.chest.2020.01.026_bib33","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","article-title":"Self-report measures of medication adherence behavior: recommendations on optimal use","volume":"5","author":"Stirratt","year":"2015","journal-title":"Transl Behav Med"},{"issue":"3","key":"10.1016\/j.chest.2020.01.026_bib34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/resp.12059","article-title":"Accuracy of patient self-report as a measure of inhaled asthma medication use","volume":"18","author":"Patel","year":"2013","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.chest.2020.01.026_bib35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1177\/1060028014522982","article-title":"Accuracy of the Medication Adherence Report Scale (MARS-5) as a quantitative measure of adherence to inhalation medication in patients with COPD","volume":"48","author":"Tommelein","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"11","key":"10.1016\/j.chest.2020.01.026_bib36","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1089\/dia.2010.0058","article-title":"Health literacy, diabetes self-care, and glycemic control in adults with type 2 diabetes","volume":"12","author":"Osborn","year":"2010","journal-title":"Diabetes Technol Therap"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220302397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220302397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:18:38Z","timestamp":1757924318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369220302397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0012369220302397"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2020.01.026","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Medication Adherence and Clinical Outcomes in Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2020.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}